On the heels of releasing its latest financial statement, Vancouver-based biotechnology company Absci announced it has met its first milestone in its collaboration with pharmaceutical giant AstraZenec ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback